By Counterforce Health Team in Filsuvez (birch triterpenes topical gel) —

How to Get Filsuvez Covered by Aetna CVS Health in Georgia: Prior Authorization, Appeals & State Protections

Answer Box: Getting Filsuvez Covered by Aetna CVS Health in Georgia

Filsuvez requires prior authorization from Aetna CVS Health and is typically non-formulary, but approval is possible with proper documentation. Your fastest path: 1) Confirm your EB subtype with genetic testing, 2) Document failed trials of 2-3 formulary wound care alternatives, 3) Submit PA through CVS Specialty (1-866-814-5506) with specialist support. If denied, you have 180 days for internal appeals and 120 days for Georgia's free external review. Start by calling CVS Specialty today to confirm current requirements.

Table of Contents

Plan Types & Coverage Implications

Your Aetna CVS Health plan type affects how Filsuvez coverage works in Georgia. Commercial PPO plans typically offer the most flexibility for specialty drugs, while HMO plans may require referrals to dermatology or EB specialists before coverage consideration.

Medicaid managed care plans through Aetna Better Health Georgia follow different formulary guidelines and may have additional state-mandated coverage requirements for rare disease treatments. Medicare Advantage plans must follow CMS guidelines but can apply their own prior authorization criteria.

Note: Regardless of plan type, all Aetna members have the same appeals rights in Georgia, including access to the state's external review process.

Formulary Status & Tier Placement

Filsuvez is classified as non-formulary on most Aetna CVS Health plans, meaning it requires a formulary exception for coverage. The drug doesn't appear on standard formulary tiers due to its recent FDA approval (December 2024) and high cost—approximately $27,631 for common quantities according to GoodRx.

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all plans CVS Specialty: 1-866-814-5506 Aetna PA Portal
Formulary Status Non-formulary/exception needed Plan formulary documents Aetna Drug Lists
Step Therapy 2-3 alternatives required Policy documentation Coverage Policies
Age Requirement ≥6 months with confirmed EB FDA labeling FDA Approval
Diagnosis Codes Specific EB subtype ICD-10 Medical records Clinical documentation
Appeals Deadline 180 days internal, 120 days external Denial letters Georgia DOI

Prior Authorization Requirements

Aetna CVS Health requires comprehensive documentation for Filsuvez approval. The prior authorization process involves several key components that must be submitted together for the strongest case.

Medical Necessity Documentation

Confirmed EB Diagnosis: You need genetic testing results confirming junctional or dystrophic epidermolysis bullosa. For dystrophic EB, this means documentation of COL7A1 gene mutations. For junctional EB, genetic confirmation of causative mutations is expected, though Aetna's policies don't specify exact genes.

Clinical Evidence: Submit detailed wound assessments with photographs showing measurements and progression over 3-6 months, pain assessments, and quality-of-life impact documentation. Include specific ICD-10 codes for your EB subtype.

Specialist Support: Dermatology or EB center consultation notes carry significant weight in the approval process. These specialists can provide the clinical rationale that standard wound care approaches are insufficient.

Step Therapy & Alternative Treatments

Before approving Filsuvez, Aetna requires documented trials and failures of formulary alternatives. This step therapy requirement typically involves 2-3 standard wound care treatments over 3-6 months.

Required Alternative Trials

Standard Topical Treatments:

  • Silver sulfadiazine cream
  • Mupirocin ointment
  • Bacitracin/polymyxin combinations

Advanced Wound Dressings:

  • Non-adherent silicone dressings
  • Hydrocolloid dressings
  • Foam or alginate dressings

Documentation Requirements:

  • Specific products used and duration of trial
  • Clinical outcomes and wound progression
  • Reasons for discontinuation (ineffective, intolerance, adverse effects)
  • Photographic evidence of wound status before, during, and after each trial
Tip: Keep detailed wound care logs with photos and measurements. This documentation becomes crucial for both initial PA requests and potential appeals.

CVS Specialty Pharmacy Process

Once approved, Filsuvez is dispensed through CVS Specialty Pharmacy, which coordinates with your care team for delivery and clinical support.

Enrollment Steps

  1. PA Approval: Ensure prior authorization is complete before pharmacy enrollment
  2. Prescription Transfer: Your prescriber sends the prescription to CVS Specialty
  3. Patient Enrollment: CVS Specialty contacts you to set up delivery and clinical support
  4. Ongoing Coordination: Pharmacy monitors refills and coordinates with your care team

Contact Information:

  • CVS Specialty Pharmacy: 1-800-238-7828
  • Aetna Specialty PA: 1-866-814-5506

Cost-Share Considerations

Your out-of-pocket costs depend on your specific plan design, but specialty drugs like Filsuvez typically fall under the highest cost-sharing tier.

Typical Cost Structure:

  • Deductible: May apply before coverage begins
  • Coinsurance: Often 20-40% for specialty drugs
  • Out-of-pocket maximum: Provides annual protection

Cost-Saving Resources:

  • Manufacturer patient assistance programs
  • Foundation grants for rare diseases (NORD, EB-specific organizations)
  • State pharmaceutical assistance programs in Georgia
Note: This is educational information only. Consult your specific plan documents for exact cost-sharing details.

Submission Process & Forms

Step-by-Step: Fastest Path to Approval

  1. Gather Documentation (Patient/Clinic): Collect genetic testing, wound photos, prior treatment records, specialist notes
  2. Contact CVS Specialty (Clinic): Call 1-866-814-5506 to confirm current PA requirements and obtain forms
  3. Submit Complete PA (Prescriber): Include all required documentation via fax (1-866-249-6155) or electronic portal
  4. Follow Up (Patient/Clinic): Track submission status and respond to any requests for additional information
  5. Receive Decision (15 business days): Standard reviews take up to 15 business days; expedited reviews within 24-72 hours
  6. Appeal if Denied (Within 180 days): Submit internal appeal with additional supporting evidence
  7. External Review (If needed): Request Georgia external review within 120 days of final internal denial

Required Forms and Portals

Submit through Aetna's provider portal or via fax. Ensure all documentation is clearly labeled and includes:

  • Patient demographics and insurance information
  • Complete medical history and diagnosis
  • Treatment history and outcomes
  • Clinical rationale for Filsuvez specifically

Appeals Process in Georgia

Georgia provides strong consumer protections for insurance appeals, including a robust external review process.

Internal Appeals with Aetna

Timeline: File within 180 days of denial Decision Time: 45 business days for standard appeals, 36-72 hours for expedited appeals Process: Submit appeal form with additional supporting documentation

Georgia External Review

After exhausting internal appeals, Georgia residents can request an independent external review.

Eligibility: Denials based on medical necessity or experimental/investigational determinations Timeline: Request within 120 days of final internal denial Cost: Free to consumers Decision Time: 30 days for standard review, 72 hours for expedited Outcome: Binding on Aetna if approved

How to Request: Contact the Georgia Department of Insurance Consumer Services at 1-800-656-2298 or submit the external review application available on the Georgia DOI website.

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
Lack of genetic confirmation Submit genetic testing results COL7A1 mutation results for dystrophic EB
Insufficient alternative trials Document 2-3 failed treatments Treatment logs with outcomes and photos
Missing specialist support Obtain dermatology consultation Specialist notes supporting medical necessity
Experimental/investigational Cite FDA approval and guidelines FDA labeling, clinical guidelines, peer-reviewed studies
Age requirement not met Confirm patient age ≥6 months Birth certificate or medical records

State Protections & External Review

Georgia's external review process is particularly strong for rare disease treatments like Filsuvez. The state's independent review organizations include physicians familiar with epidermolysis bullosa and specialty wound care.

Key Georgia Protections:

  • 120-day window for external review requests
  • Expedited review available for urgent situations
  • No cost to consumers
  • Binding decisions on insurers
  • Consumer assistance through Georgia DOI

Getting Help:

Patient Resources & Support

Clinical Support

EB Specialty Centers: Connect with epidermolysis bullosa centers that have experience with insurance approvals and can provide stronger clinical documentation.

Wound Care Specialists: Dermatologists with wound care expertise can provide detailed assessments that support medical necessity.

Financial Assistance

Manufacturer Support: Chiesi Global Rare Diseases may offer patient assistance programs for eligible patients.

Foundation Grants: Organizations like the National Organization for Rare Disorders (NORD) provide grants for rare disease treatments.

State Programs: Georgia may have pharmaceutical assistance programs for residents meeting income requirements.

Advocacy Support

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform helps patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with payer-specific rules.

For EB patients facing coverage challenges, having expert support can make the difference between approval and denial. Counterforce Health's system pulls the right clinical evidence—FDA labeling, peer-reviewed studies, and specialty guidelines—and weaves them into appeals that meet procedural requirements while tracking deadlines and required documentation.

From Our Advocates

We've seen EB families succeed with Filsuvez approvals when they combine strong clinical documentation with persistent advocacy. One key pattern: families who maintained detailed wound care logs with photos and worked closely with EB specialists had higher approval rates. The combination of genetic confirmation, failed alternative trials, and specialist support creates the strongest foundation for approval.

FAQ

How long does Aetna CVS Health prior authorization take for Filsuvez in Georgia? Standard PA decisions take up to 15 business days. Expedited reviews for urgent medical situations can be completed within 24-72 hours.

What if Filsuvez is non-formulary on my plan? You can request a formulary exception with medical necessity documentation. This requires demonstrating that formulary alternatives have failed or are inappropriate.

Can I request an expedited appeal in Georgia? Yes, both Aetna internal appeals and Georgia external reviews offer expedited processes when delays could seriously jeopardize your health.

Does step therapy apply if I tried alternatives outside Georgia? Yes, documented trials from any provider can satisfy step therapy requirements as long as the documentation is complete and verifiable.

What happens if my external review is approved? Aetna must cover the treatment as directed by the external review decision. The decision is binding and ends the administrative appeals process.

Can I get temporary coverage while appealing? You can request 30-90 day temporary coverage during the exception or appeal process to avoid treatment gaps.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and state regulations may change. Always consult your specific plan documents and healthcare providers for personalized guidance.

For official Georgia insurance information, visit the Georgia Department of Insurance or call their consumer hotline at 1-800-656-2298.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.